Although IL-6 has previously been connected with squamous cell carcinoma bone invasion, which occurs during late stages of the disease[54], the highest concentration of this cytokine was detected at the beginning of DMBA-treatment. The gene discussed is IL6; the disease is squamous cell carcinoma.